Treatment success rate for patients treated for MDR-TB in High income (World Bank)
High income (World Bank): Treatment success rate for patients treated for MDR-TB was 65.0% in 2022. ▬ Flat
Latest (2022)
65.0%
Change on year
up 18.2%
Rank
10th
of 11 groups
All-time high
78.0%
in 2001
All-time low
31.0%
in 2007
Years of data
24
1999–2022
Treatment success rate for patients treated for MDR-TB in High income (World Bank), 1999–2022
Source: World Health Organization, Global Health Observatory.
Analysis
In 2022, treatment success rate for patients treated for mdr-tb in High income (World Bank) stood at 65.0%.
That represents a change of up 18.2% on the previous year and up 54.8% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in High income (World Bank) peaked at 78.0% in 2001 and was at its lowest, 31.0%, in 2007.
Treatment success rate for patients treated for MDR-TB in High income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 1999 | 50.0% | — |
| 2000 | 68.0% | +36.0% |
| 2001 | 78.0% | +14.7% |
| 2002 | 47.0% | -39.7% |
| 2003 | 45.0% | -4.3% |
| 2004 | 44.0% | -2.2% |
| 2005 | 66.0% | +50.0% |
| 2006 | 41.0% | -37.9% |
| 2007 | 31.0% | -24.4% |
| 2008 | 41.0% | +32.3% |
| 2009 | 35.0% | -14.6% |
| 2010 | 42.0% | +20.0% |
| 2011 | 39.0% | -7.1% |
| 2012 | 42.0% | +7.7% |
| 2013 | 49.0% | +16.7% |
| 2014 | 51.0% | +4.1% |
| 2015 | 54.0% | +5.9% |
| 2016 | 54.0% | +0.0% |
| 2017 | 56.0% | +3.7% |
| 2018 | 52.0% | -7.1% |
| 2019 | 52.0% | +0.0% |
| 2020 | 52.0% | +0.0% |
| 2021 | 55.0% | +5.8% |
| 2022 | 65.0% | +18.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 50.0% | 50.0% | 50.0% | 1 |
| 2000s | 49.6% | 31.0% | 78.0% | 10 |
| 2010s | 49.1% | 39.0% | 56.0% | 10 |
| 2020s | 57.3% | 52.0% | 65.0% | 3 |
More health data for High income (World Bank)
- Measles - number of reported cases, gaps filled 25,070 (2025)
- Diphtheria - number of reported cases, gaps filled 235 (2025)
- Total tetanus - number of reported cases, gaps filled 205 (2025)
- Pertussis - number of reported cases, gaps filled 178,482 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Number of under-five deaths, annual growth rate -1.48 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate 0.1729 % change on previous year (2024)
- Number of infant deaths, annual growth rate -1.31 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -56.94 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -56.32 % change on previous year (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in High income (World Bank)?
- Treatment success rate for patients treated for mdr-tb in High income (World Bank) was 65.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in High income (World Bank)?
- The highest recorded value was 78.0% in 2001.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in High income (World Bank)?
- The lowest recorded value was 31.0% in 2007.
- How does High income (World Bank) rank for treatment success rate for patients treated for mdr-tb?
- High income (World Bank) ranks 10th out of 11 groups with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in High income (World Bank)?
- Over the last ten years it is up 54.8%. The long-run trend across the full record is flat.
- Where does this High income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).